Clinical trials: Superficial Siderosis
Superficial Siderosis
Observational Study of Deferiprone (Ferriprox®) in the Treatment of Superficial Siderosis
Superficial siderosis is a progressive neurological disease caused by iron deposition in the central nervous system (CNS) from chronic subarachnoid bleeding.
- Trial name
- NCT01284127
- Where
- United States
- Volunteers
- 38 people
- Sponsor
- Johns Hopkins University